Scholar Progress Reports

Taubman Scholars are required to submit an annual report on the progress of the research funded by their Taubman Institute grant. These progress reports are due on the anniversary of the effective date of the grant. For most Taubman Scholars and Senior Scholars, that would be July 1; however, for some Emerging Scholars and Taubman Scholars, the effective date of the grant could be different. We encourage Scholars to check their letter of appointment to confirm the effective date.

As the letter of appointment states, the annual report should set forth the research plan, progress on the plan, any findings to date, any publications based on this research, any issues, and any other relevant material. As the NIH suggests, the report should be written in language understandable to a biomedical scientist who may not be a specialist in the project's research field. Abbreviations and language that may not be known to the broader scientific community should be avoided unless clearly defined.

These progress reports will be submitted to the Taubman Institute’s Scientific Advisory Board for review, as well as distributed to the organization’s Governing Council. They will be also used to facilitate the Taubman Institute’s communications, community outreach and public engagement efforts.

To simplify the task and to ensure consistency, the Taubman Institute asks that Scholars use Progress Report form below for all submissions.

Progress Report Form


  or Reset
 

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists